Menu Close

Articles on RandD

Displaying 761 - 780 of 2954 articles

Afrigen, a biotechnology company based in Cape Town, South Africa, is developing Africa’s first proprietary COVID-19 vaccine. Kristin Palitza/picture alliance via Getty Images

How trying to copy a COVID vaccine changes the outlook for African countries

With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.
New technologies can bolster the production of important crops to feed billions of people. Shutterstock

South Africa should rethink regulations on genetically modified plants

A regulatory approach will place an unnecessary burden on bio-innovators. This will discourage local investment for in-house R&D, as well as projects in the public sector.
The large public health apparatus assembled to fight Ebola created more problems. Alexis Huguet/AFP via Getty Images

Lessons from the DRC’s 10th Ebola epidemic: the people may know best

International epidemic management involves ceding to foreign experts who possess, at best, a surface-level understanding of a very complex region.

Top contributors

More